myHealthbox is recognized as the largest, independent drug database, offering official information on medicines and healthcare products across over 90 countries. What sets them apart is their platform which not only provides information but also designs and distributes a digital leaflet, known as eLeaflet or ePIL, specifically tailored for healthcare. This digital version complements the conventional paper documents found in product packaging, thus enhancing the accessibility and convenience of vital healthcare information for professionals and patients alike.
Although the specific details about the headquarter and the last investment are currently unavailable, myHealthbox’s global reach and innovative approach to digital healthcare solutions position them as a promising contender in the rapidly evolving digital health landscape.